Healio7h
AI tool predicts response to, survival after treatment with immune checkpoint inhibitors
An AI tool appeared superior to two FDA-approved biomarkers for predicting how people with cancer will respond to immune ...
Taiwan News9h
OnCusp Therapeutics Receives FDA Fast Track Designation for CUSP06 for the Treatment of Platinum-Resistant Ovarian Cancer
"We are extremely pleased that the FDA granted Fast Track Designation to CUSP06," said Eric Slosberg, PhD, Chief Development Officer of OnCusp Therapeutics. "The early results from our Phase 1 trial ...
Frontiers10h
Exploring Small Molecule Inhibitors in Cancer, Inflammation, and Autoimmune Disorders
Given the success of the previous Research Topic 'Exploring Small Molecule Inhibitors in Cardiovascular and Cerebrovascular Diseases', we are pleased to ...